Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers.

Gonzalez M, Keating RJ, Markowitz SM, Liu CF, Thomas G, Ip JE, Lerman BB, Cheung JW.

Heart Rhythm. 2014 Dec;11(12):2214-21. doi: 10.1016/j.hrthm.2014.08.019. Epub 2014 Aug 15.

PMID:
25131667
2.

Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.

Ricci RP, Botto GL, Bénézet JM, Nielsen JC, De Roy L, Piot O, Quesada A, Quaglione R, Vaccari D, Mangoni L, Grammatico A, Kozák M; PreFER MVP Investigators.

Heart Rhythm. 2015 Nov;12(11):2239-46. doi: 10.1016/j.hrthm.2015.06.041. Epub 2015 Jun 30.

PMID:
26142300
3.

Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy.

Witt CT, Kronborg MB, Nohr EA, Mortensen PT, Gerdes C, Nielsen JC.

Heart Rhythm. 2015 Dec;12(12):2368-75. doi: 10.1016/j.hrthm.2015.07.007. Epub 2015 Jul 8.

PMID:
26164377
4.

Risk factors for bradycardia requiring pacemaker implantation in patients with atrial fibrillation.

Barrett TW, Abraham RL, Jenkins CA, Russ S, Storrow AB, Darbar D.

Am J Cardiol. 2012 Nov 1;110(9):1315-21. doi: 10.1016/j.amjcard.2012.06.037. Epub 2012 Jul 26.

5.

Subclinical atrial fibrillation and the risk of stroke.

Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH; ASSERT Investigators.

N Engl J Med. 2012 Jan 12;366(2):120-9. doi: 10.1056/NEJMoa1105575. Erratum in: N Engl J Med. 2016 Mar 10;374(10):998.

6.

New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.

Padeletti L, Pürerfellner H, Mont L, Tukkie R, Manolis AS, Ricci R, Inama G, Serra P, Scheffer MG, Martins V, Warman EN, Vimercati M, Grammatico A, Boriani G; MINERVA Investigators.

Heart Rhythm. 2015 Aug;12(8):1717-25. doi: 10.1016/j.hrthm.2015.04.015. Epub 2015 Apr 11.

7.

The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality.

Ousdigian KT, Borek PP, Koehler JL, Heywood JT, Ziegler PD, Wilkoff BL.

Circ Arrhythm Electrophysiol. 2014 Jun;7(3):370-6. doi: 10.1161/CIRCEP.113.001212. Epub 2014 May 17.

8.

Frequency, duration, and predictors of newly-diagnosed atrial fibrillation following dual-chamber pacemaker implantation in patients without a previous history of atrial fibrillation.

Mittal S, Stein K, Gilliam FR 3rd, Kraus SM, Meyer TE, Christman SA.

Am J Cardiol. 2008 Aug 15;102(4):450-3. doi: 10.1016/j.amjcard.2008.03.080. Epub 2008 Jun 12.

PMID:
18678304
9.

Atrial dysfunction and interatrial dyssynchrony predict atrial high rate episodes: insight into the distinct effects of right atrial appendage pacing.

Xie JM, Fang F, Zhang Q, Chan JY, Yip GW, Sanderson JE, Lam YY, Yan BP, Yu CM.

J Cardiovasc Electrophysiol. 2012 Apr;23(4):384-90. doi: 10.1111/j.1540-8167.2011.02210.x. Epub 2011 Nov 7.

PMID:
22059778
10.

Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.

Boriani G, Tukkie R, Manolis AS, Mont L, Pürerfellner H, Santini M, Inama G, Serra P, de Sousa J, Botto GL, Mangoni L, Grammatico A, Padeletti L; MINERVA Investigators.

Eur Heart J. 2014 Sep 14;35(35):2352-62. doi: 10.1093/eurheartj/ehu165. Epub 2014 Apr 25.

11.

Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT.

Kaufman ES, Israel CW, Nair GM, Armaganijan L, Divakaramenon S, Mairesse GH, Brandes A, Crystal E, Costantini O, Sandhu RK, Parkash R, Connolly SJ, Hohnloser SH, Healey JS; ASSERT Steering Committee and Investigators.

Heart Rhythm. 2012 Aug;9(8):1241-6. doi: 10.1016/j.hrthm.2012.03.017. Epub 2012 Mar 20.

PMID:
22440154
12.

ECG Features Associated With Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation: A Combined AFFIRM and AF-CHF Analysis.

Andrade JG, Roy D, Wyse DG, Dorian P, Talajic M, Leduc H, Cadrin-Tourigny J, Shohoudi A, Macle L, Thibault B, Guerra PG, Rivard L, Dubuc M, Khairy P.

J Cardiovasc Electrophysiol. 2016 Apr;27(4):404-13. doi: 10.1111/jce.12934. Epub 2016 Feb 25.

PMID:
27074775
13.

Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST).

Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook J, Paraschos A, Love J, Radoslovich G, Lee KL, Lamas GA; MOST Investigators.

Circulation. 2003 Apr 1;107(12):1614-9. Epub 2003 Mar 24.

14.

Newly detected atrial fibrillation following dual chamber pacemaker implantation.

Cheung JW, Keating RJ, Stein KM, Markowitz SM, Iwai S, Shah BK, Lerman BB, Mittal S.

J Cardiovasc Electrophysiol. 2006 Dec;17(12):1323-8. Epub 2006 Nov 1.

PMID:
17081212
15.

Atrial pacing for the prevention and termination of atrial fibrillation.

Savelieva I, Camm AJ.

Am J Geriatr Cardiol. 2002 Nov-Dec;11(6):380-98. Review.

PMID:
12417845
16.

Predictors and risk of pacemaker implantation after the Cox-maze IV procedure.

Robertson JO, Cuculich PS, Saint LL, Schuessler RB, Moon MR, Lawton J, Damiano RJ, Maniar HS.

Ann Thorac Surg. 2013 Jun;95(6):2015-20; disussion 2020-1. doi: 10.1016/j.athoracsur.2013.03.064. Epub 2013 Apr 30.

17.

The natural history of atrial fibrillation in patients with permanent pacemakers: is atrial fibrillation a progressive disease?

Veasey RA, Sugihara C, Sandhu K, Dhillon G, Freemantle N, Furniss SS, Sulke AN.

J Interv Card Electrophysiol. 2015 Oct;44(1):23-30. doi: 10.1007/s10840-015-0029-x. Epub 2015 Jul 3.

PMID:
26139311
18.

Rates of Atrial Fibrillation in Black Versus White Patients With Pacemakers.

Kamel H, Kleindorfer DO, Bhave PD, Cushman M, Levitan EB, Howard G, Soliman EZ.

J Am Heart Assoc. 2016 Feb 12;5(2). pii: e002492. doi: 10.1161/JAHA.115.002492.

19.

A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome.

Nielsen JC, Thomsen PE, Højberg S, Møller M, Vesterlund T, Dalsgaard D, Mortensen LS, Nielsen T, Asklund M, Friis EV, Christensen PD, Simonsen EH, Eriksen UH, Jensen GV, Svendsen JH, Toff WD, Healey JS, Andersen HR; DANPACE Investigators.

Eur Heart J. 2011 Mar;32(6):686-96. doi: 10.1093/eurheartj/ehr022. Epub 2011 Feb 7.

PMID:
21300730
20.

Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.

Benezet-Mazuecos J, Rubio JM, Cortés M, Iglesias JA, Calle S, de la Vieja JJ, Quiñones MA, Sanchez-Borque P, de la Cruz E, Espejo A, Farré J.

Europace. 2015 Mar;17(3):364-9. doi: 10.1093/europace/euu267. Epub 2014 Oct 21.

PMID:
25336664

Supplemental Content

Support Center